Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ED✓SelectedUSD · EDGSK vs ED performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs ED

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+43.0%
ED return
+81.4%
Excess return
-38.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioEDExcessAlpha
1D-2.3%-2.2%-0.1%-1.5%
7D-3.0%0.0%-3.0%-3.0%
30D+0.4%+6.2%-5.9%-1.8%
3M-1.2%+10.3%-11.5%-4.7%
6M+0.9%+14.1%-13.2%-3.8%
YTD+4.0%+23.0%-19.0%-3.6%
1Y+7.3%+18.6%-11.3%+0.7%
3Y+57.1%+43.2%+13.9%+37.7%
5Y+43.0%+81.1%-38.1%+17.6%
All+43.0%+81.4%-38.4%+17.6%

Cumulative growth

Daily Returns

Daily percentage return beside ED.

Daily Out/Under-Performance

Portfolio return minus ED return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ED return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded ED wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling